article Open AccessTop 1% cited
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology · 2021 · Vol. 32(11) · pp. 1348–1365
Alessandro Gronchi✉(Fondazione IRCCS Istituto Nazionale dei Tumori)Aisha Miah(Institute of Cancer Research)Angelo Paolo Dei Tos(Azienda Ospedaliera di Padova)N. AbecassisJyoti Bajpai(Tata Memorial Hospital)Sebastian Bauer(University of Duisburg-Essen)R. Biagini(Istituti di Ricovero e Cura a Carattere Scientifico)Stefan Bielack(Olgahospital)Jean‐Yves Blay(Université Claude Bernard Lyon 1)Stéphanie Bolle(Institut Gustave Roussy)Sylvie Bonvalot(Institut Curie)I. BoukovinasJudith V.M.G. Bovée(Leiden University Medical Center)Kjetil Boye(Oslo University Hospital)Bernadette Brennan(Royal Manchester Children's Hospital)Thomas Brodowicz(Vienna General Hospital)Angela Buonadonna(Centro di Riferimento Oncologico)Enrique de Álava(Universidad de Sevilla)Xavier García del MuroArmelle Dufresne(Centre Léon Bérard)Mikael Eriksson(Skåne University Hospital)Franca Fagioli(University of Turin)А. А. Феденко(P.A. Hertzen Moscow Oncology Research Institute)Virginia Ferraresi(Istituti di Ricovero e Cura a Carattere Scientifico)Andrea Ferrari(Fondazione IRCCS Istituto Nazionale dei Tumori)Anna Maria Frezza(Fondazione IRCCS Istituto Nazionale dei Tumori)Silvia Gasperoni(Azienda Ospedaliero-Universitaria Careggi)Hans Gelderblom(Leiden University Medical Center)F. Gouin(Centre Léon Bérard)Giovanni Grignani(Istituti di Ricovero e Cura a Carattere Scientifico)Rick L. Haas(Leiden University)A.B. Hassan(University of Oxford)Stefanie Hecker‐Nolting(Olgahospital)Nadia Hindi(Hospital Universitario Fundación Jiménez Díaz)Peter Hohenberger(University Hospital Heidelberg)Heikki Joensuu(University of Helsinki)Robin L. Jones(Institute of Cancer Research)Christiane Jungels(Institut Jules Bordet)Paul C. Jutte(University Medical Center Groningen)Leo Kager(St Anna Children's Hospital)Bernd Kasper(University Medical Centre Mannheim)Akira KawaiKateřina Kopečková(University Hospital in Motol)Dagmar Adámková Krákorová(Masaryk Memorial Cancer Institute)Axel Le Cesne(Institut Gustave Roussy)Franel Le Grange(University College London Hospitals NHS Foundation Trust)Eric Legius(KU Leuven)Andreas Leithner(Medical University of Graz)Antonio López–Pousa(Hospital de Sant Pau)Javier Martín‐Broto(Hospital Universitario Fundación Jiménez Díaz)Ofer Merimsky(Tel Aviv Sourasky Medical Center)Christina Messiou(Institute of Cancer Research)Olivier Mir(Institut Gustave Roussy)Michael Montemurro(University Hospital of Lausanne)Bruce Morland(Birmingham Women’s and Children’s NHS Foundation Trust)Carlo Morosi(Istituti di Ricovero e Cura a Carattere Scientifico)Emanuela Palmerini(Istituto Ortopedico Rizzoli)Maria A. Pantaleo(Azienda USL di Bologna)Raimondo Piana(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)Sophie Piperno‐Neumann(Institut Curie)Peter Reichardt(Helios Hospital Berlin-Buch)Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology)Akmal Safwat(Aarhus University Hospital)Claudia Sangalli(Fondazione IRCCS Istituto Nazionale dei Tumori)Marta Sbaraglia(Azienda Ospedaliera di Padova)Susanne Scheipl(Medical University of Graz)Patrick Schöffski(KU Leuven)Stefan Sleijfer(Erasmus MC Cancer Institute)D. Strauß(Royal Marsden Hospital)Sandra J. Strauss(University College London Hospitals NHS Foundation Trust)Kirsten Sundby Hall(Oslo University Hospital)Annalisa Trama(Fondazione IRCCS Istituto Nazionale dei Tumori)Mojca Unk(Institute of Oncology Ljubljana)Michiel A. J. van de Sande(Leiden University Medical Center)Winette T.A. van der Graaf(Erasmus MC Cancer Institute)Winan J. van Houdt(The Netherlands Cancer Institute)Thierry Frébourg(Normandie Université)Paolo G. Casali(University of Milan)Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale dei Tumori)
Sarcoma Diagnosis and TreatmentVascular Tumors and AngiosarcomasSoft tissue tumors and treatmentMedicineGuidelineClinical PracticeSoft tissueMultidisciplinary approachFamily medicineMedical physicsSurgeryPathology
MeSH terms
Follow-Up StudiesHumansSarcomaSoft Tissue Neoplasms
Funding
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Regeneron Pharmaceuticals
- European Musculoskeletal Oncology Society
- Bundesinstitut für Arzneimittel und Medizinprodukte
- Incyte
- Daiichi-Sankyo
- Eisai
- Astellas Pharma
- Institut National Du Cancer
- European Society for Medical Oncology
- PharmaMar
- Sun Pharma
- Ipsen
- Plexxikon
- Samsung
Citations
909
FWCI
91.58
field-weighted impact
References
98
Percentile
100%
vs. same field & year
Citations per year
References
Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
International Journal of Cancer · 1984 · 1,295 citations
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
European Journal of Cancer · 2008 · 526 citations
The Treatment of Soft-tissue Sarcomas of the Extremities
Annals of Surgery · 1982 · 1,348 citations
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
The Lancet Oncology · 2019 · 1,690 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
